oseltamivir has been researched along with Autoimmune Thrombocytopenia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 4 (57.14) | 2.80 |
Authors | Studies |
---|---|
Ahmadi, Z; Chong, BH; Leung, HHL; Perdomo, JS; Wong, R; Yan, F; Zheng, SS | 1 |
Cantú-Rodríguez, OG; Colunga-Pedraza, JE; Colunga-Pedraza, PR; De la Garza-Salazar, F; Gómez-Almaguer, D; Gómez-De León, A; Peña-Lozano, SP; Sánchez-Rendón, E; Santana-Hernández, P | 1 |
Neunert, C | 1 |
Han, P; Hou, M; Hou, Y; Li, D; Liu, X; Peng, J; Qiu, J; Shao, L; Sun, L; Wang, J; Wang, Z; Xu, M; Yu, Y; Yuan, C; Zhao, H; Zhou, H | 1 |
Hou, M; Ni, H; Peng, J; Qin, P; Shao, L; Wu, Y; Zhou, H | 1 |
Álvarez-Román, MT; Bernardino, JI; Butta, NV; Fernández-Bello, I; Jiménez-Yuste, V; Lozano, ML; Martín-Salces, M; Rivas Pollmar, MI | 1 |
Alioglu, B; Dallar, Y; Ozen, C; Selver, B; Tasar, A | 1 |
1 review(s) available for oseltamivir and Autoimmune Thrombocytopenia
Article | Year |
---|---|
Oseltamivir as rescue therapy for persistent, chronic, or refractory immune thrombocytopenia: a case series and review of the literature.
Topics: Humans; Oseltamivir; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Treatment Outcome | 2022 |
1 trial(s) available for oseltamivir and Autoimmune Thrombocytopenia
Article | Year |
---|---|
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.
Topics: Administration, Oral; Adult; China; Dexamethasone; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Glucocorticoids; Hemorrhage; Humans; Intention to Treat Analysis; Male; Middle Aged; Oseltamivir; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Safety; Treatment Outcome | 2021 |
5 other study(ies) available for oseltamivir and Autoimmune Thrombocytopenia
Article | Year |
---|---|
Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia.
Topics: Animals; Antibodies; Apoptosis; Autoantibodies; Blood Platelets; Humans; Mice; Oseltamivir; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | 2022 |
Looking long-term: an unmet need in immune thrombocytopenia.
Topics: Dexamethasone; Health Services Needs and Demand; Humans; Oseltamivir; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | 2021 |
Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody.
Topics: Aged; Autoantibodies; Humans; Male; Oseltamivir; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2015 |
Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.
Topics: Anti-HIV Agents; HIV Infections; Humans; Male; Middle Aged; Oseltamivir; Purpura, Thrombocytopenic, Idiopathic; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombopoietin; Treatment Outcome | 2016 |
An experience of oseltamivir phosphate (tamiflu™) in a pediatric patient with chronic idiopathic thrombocytopenic purpura: a case report.
Topics: Adolescent; Antiviral Agents; Chronic Disease; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2010 |